>北美辅料市场，按来源（有机、无机）、类别（主要辅料、次要辅料）、产品（聚合物、糖、酒精、矿物质、明胶、其他）、化学类型（植物、动物、合成、矿物质）、化学合成（乳糖一水合物、三氯蔗糖、聚山梨醇酯、苯甲醇、十六烷基硬脂醇、大豆卵磷脂、预胶化淀粉、其他）、功能（粘合剂和胶粘剂、崩解剂、涂层材料、崩解剂、增溶剂、调味剂、甜味剂、稀释剂、润滑剂、缓冲剂、乳化剂、防腐剂、抗氧化剂、吸附剂、溶剂、润肤剂、助流剂、螯合剂、消泡剂、其他）、剂型（固体、半固体、液体）、给药途径（口服辅料、外用辅料、肠外辅料、其他辅料）、最终用户（制药和生物制药公司、合同配方师、研究组织和学者等）、分销渠道（直接招标、零售销售等）、国家（美国、加拿大、墨西哥）行业趋势和预测（至 2028 年）
市场分析和见解：北美辅料市场
预计辅料市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，市场复合年增长率为 5.9%，预计到 2028 年将达到 62.9682 亿美元。对替代给药途径/剂型的需求不断增加以及各个治疗领域对药用辅料的需求不断增加是预测期内推动辅料市场需求的主要驱动力。
药用辅料包括药物中除活性药物成分以外的所有成分。这些分子不具有任何药用特性，最终用于增强药物的生理吸收。辅料本质上是惰性的，它使药物分子能够以正确的形式应用于患者。
多功能辅料的技术进步将成为预测期内辅料市场增长的驱动力。药物开发过程的漫长预计将阻碍预测期内辅料市场的发展。市场参与者的战略举措为辅料市场的增长提供了机遇。储存和运输中的安全考虑对辅料市场的增长提出了挑战。
辅料市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和辅料市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
辅料市场范围和市场规模
辅料市场根据产地、类别、产品、化学类型、化学合成、功能、剂型、给药途径、最终用户和分销渠道分为十个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据来源，赋形剂市场分为有机赋形剂和无机赋形剂。2021 年，有机赋形剂占据最高的市场份额，因为用作赋形剂的有机化学品具有无毒特性。
- 根据类别，辅料市场分为主要辅料和次要辅料。2021 年，主要辅料领域占据市场主导地位，因为该领域包括填料、粘合剂、润滑剂和其他关键辅料。
- 根据产品，辅料市场细分为聚合物、糖、酒精、矿物质、明胶和其他。2021 年，聚合物领域占据市场主导地位，因为聚合物在胶囊制造中用作明胶壳。
- 根据化学类型，辅料市场分为植物、动物、合成和矿物。2021 年，植物部分由于价格便宜、无毒、可生物降解且不会对人类产生任何不良副作用而占据市场主导地位。
- 根据化学合成，辅料市场细分为乳糖一水合物、三氯蔗糖、聚山梨醇酯、苯甲醇、十六醇十八醇、大豆卵磷脂、预胶化淀粉等。2021 年，乳糖一水合物因其多种特性而占据市场主导地位。
- 根据功能，辅料市场细分为粘合剂和胶粘剂、崩解剂、包衣材料、崩解剂、增溶剂、调味剂、甜味剂、稀释剂、润滑剂、缓冲剂、乳化剂、防腐剂、抗氧化剂、吸附剂、溶剂、润肤剂、助流剂、螯合剂、消泡剂等。2021 年，粘合剂和胶粘剂领域因其特性而占据市场主导地位。
- 根据剂型，辅料市场分为固体、半固体和液体。2021 年，固体部分占据市场主导地位，因为大多数辅料用于制造固体剂型。
- 根据给药途径，辅料市场分为口服辅料、外用辅料、肠外辅料和其他辅料。2021 年，口服辅料市场占据市场主导地位，因为包括一线治疗在内的大多数药物都以口服形式提供，且疗效最高，起效快。
- 根据最终用户，辅料市场细分为制药和生物制药公司、合同配方商、研究机构和学术机构等。2021 年，制药和生物制药公司在市场中占据主导地位，因为大多数辅料用于制药和生物制药公司，因为这些公司负责生产所有剂型的药物，例如固体、半固体和液体。
- 根据分销渠道，辅料市场分为直接招标、零售和其他。2021 年，直接招标部分在市场中占据主导地位，因为它是辅料分销的主要来源。
北美辅料市场国家级分析
对北美辅料市场进行分析，并根据上述国家、原产地、类别、产品、化学类型、化学合成、功能、剂型、给药途径、最终用户和分销渠道提供市场规模信息。
北美辅料市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于生物制药的创新、对孤儿药的关注度不断提高以及多功能辅料的技术进步，美国在北美辅料市场占据主导地位，预测期内复合年增长率可观。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
市场参与者的战略举措正在为辅料市场创造新的机遇
辅料市场还为您提供每个国家辅料增长情况、辅料进步的影响以及监管环境变化及其对辅料市场的支持的详细市场分析。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和辅料市场份额分析
辅料市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对北美辅料市场的关注有关。
北美辅料市场报告中涉及的主要公司包括陶氏化学、Roquette Frères、JRS Pharma、赢创工业集团、路博润公司（伯克希尔哈撒韦公司子公司）、巴斯夫 SE、阿什兰、Kerry Group PLC、信越化学株式会社、Colorcon、Chemische Fabrik Budenheim、Peter Greven GmbH & Co. KG、ADM、Croda International Plc、BENEO、Avantor, Inc.、Omya AG、Pfanstiehl, Inc.、MEGGLE Group Wasserburg 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的公司也发起了许多产品的发布和协议，这也加速了辅料市场的发展。
例如，
- 2020 年 9 月，Roquette Frères 与 Barentz 达成合作，在美国分销药品。这两家公司都在欧洲市场开展业务，创建分销渠道。此次合作将增加公司的产品组合。
合作、新产品开发和其他战略提高了公司的市场份额，扩大了覆盖范围和存在感。它还有利于组织通过扩大规模范围来改善其辅料供应。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 ORIGIN LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 NORTH AMERICA EXCIPIENTS MARKET: COUNTRIES WITH DATA OF IMPORTS AND EXPORTS
4.2 NORTH AMERICA EXCIPIETNS MARKET: COLOMBIA DATA OF THE ORIGIN COUNTRY OF THE IMPORTS
4.3 NORTH AMERICA EXCIPIENTS MARKET: COLOMBIA DATA OF THE IMPORTS AND EXPORTS BY MOLECULES IN VALUES AND VOLUMES
5 NORTH AMERICA EXCIPIENTS MARKET: REGULATORY SCENARIO
5.1 THE CANADA REGULATORY GUIDANCE FOR NON CLINICAL SAFETY EVALUATION OF PHARMACEUTICAL EXCIPIENTS
5.2 JAPAN REGULATORY FRAMEWORK FOR EXCIPIENTS
5.3 MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR EXCIPIENTS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
6.1.2 INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS
6.1.3 INNOVATIONS IN BIOPHARMACEUTICALS
6.1.4 INCREASING DEMAND & AVAILABILITY OF GENERIC DRUGS
6.1.5 RISING FOCUS ON ORPHAN DRUGS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS
6.2.2 LONG DURATION OF DRUG DEVELOPMENT PROCESS
6.2.3 HIGH COST OF EXPERIMENTAL STUDIES OF EXCIPIENTS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 RISING DEMAND FOR EASE OF USE
6.3.3 RISING DISPOSABLE INCOME
6.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS
6.3.5 ASSOCIATED SIDE EFFECTS
6.3.6 SAFETY CONSIDERATION IN STORAGE & TRANSPORTATION
6.3.7 LACK OF NOVEL PHARMACEUTICAL EXCIPIENTS
7 IMPACT OF COVID-19 ON NORTH AMERICA EXCIPIENTS MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 MPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISION BY MANUFACTURERS
7.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
7.6 CONCLUSION
8 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN
8.1 OVERVIEW
8.2 ORGANIC
8.3 INORGANIC
9 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY
9.1 OVERVIEW
9.2 PRIMARY EXCIPIENTS
9.3 SECONDARY EXCIPIENTS
10 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 POLYMERS
10.2.1 MCC
10.2.2 HPMC
10.2.3 ETHYL CELLULOSE
10.2.4 METHYL CELLULOSE
10.2.5 CMC
10.2.6 CROSCARMELLOSE SODIUM
10.2.7 POVIDONE
10.2.8 PREGELATINIZED STARCH
10.2.9 SODIUM STARCH GLYCOL
10.2.10 POLYETHYLENE GLYCOL
10.2.11 ACRYLIC POLYMERS
10.3 SUGAR
10.3.1 LACTOSE
10.3.2 SUCROSE
10.3.3 OTHERS
10.4 ALCOHOL
10.4.1 PROPYLENE GLYCOL
10.4.2 SORBITOL
10.4.3 MANNITOL
10.4.4 GLYCERIN
10.4.5 OTHERS
10.5 MINERALS
10.5.1 CALCIUM PHOSPHATE
10.5.2 CALCIUM CARBONATE
10.5.3 CLAY
10.5.4 SILICON DIOXIDE
10.5.5 TITANIUM DIOXIDE
10.5.6 OTHERS
10.6 GELATIN
10.7 OTHERS
11 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE
11.1 OVERVIEW
11.2 PLANT
11.3 ANIMALS
11.4 SYNTHETIC
11.5 MINERALS
12 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY SYNTHESIS
12.1 OVERVIEW
12.2 LACTOSE MONOHYDRATE
12.3 SUCRALOSE
12.4 POLYSORBATE
12.5 BENZYL ALCOHOL
12.6 CETOSTEARY ACLOHOL
12.7 SOY LECITHIN
12.8 PREGELATINIZED STARCH
12.9 OTHERS
13 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY
13.1 OVERVIEW
13.2 BINDERS AND ADHESIVES
13.3 DISINTEGRANTS
13.4 COATING MATERIAL
13.5 COLORING AGENTS
13.6 SOLUBILIZERS
13.7 FLAVORS
13.8 SWEETENING AGENTS
13.9 DILUENTS
13.1 LUBRICANTS
13.11 BUFFERS
13.12 EMULSIFYING AGENTS
13.13 PRESERVATIVES
13.14 ANTIOXIDANTS
13.15 SORBENTS
13.16 SOLVENTS
13.17 EMOLLIENTS
13.18 GLIDIENTS
13.19 CHELATING AGENTS
13.2 ANTIFOAMING AGENTS
13.21 OTHERS
14 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 SOLID
14.2.1 PLANT
14.2.2 ANIMALS
14.2.3 SYNTHETIC
14.2.4 MINERALS
14.3 SEMI-SOLID
14.3.1 PLANT
14.3.2 ANIMALS
14.3.3 SYNTHETIC
14.3.4 MINERALS
14.4 LIQUID
14.4.1 PLANT
14.4.2 ANIMALS
14.4.3 SYNTHETIC
14.4.4 MINERALS
15 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL EXCIPIENTS
15.3 TOPICAL EXCIPIENTS
15.4 PARENTERAL EXCIPIENTS
15.5 OTHER EXCIPIENTS
16 NORTH AMERICA EXCIPIENTS MARKET, BY END USER
16.1 OVERVIEW
16.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
16.3 CONTRACT FORMULATORS
16.4 RESEARCH ORGANIZATION AND ACADEMICS
16.5 OTHERS
17 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDER
17.3 RETAIL SALES
17.4 OTHERS
18 NORTH AMERICA EXCIPIENTS MARKET, BY GEOGRAPHY
18.1 NORTH AMERICA
18.1.1 U.S.
18.1.2 CANADA
18.1.3 MEXICO
19 NORTH AMERICA EXCIPIENTS MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 DOW
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 ROQUETTE FRÈRES
21.2.1 COMPANY SNAPSHOT
21.2.2 COMPANY SHARE ANALYSIS
21.2.3 PRODUCT PORTFOLIO
21.2.4 RECENT DEVELOPMENTS
21.3 JRS PHARMA
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENTS
21.4 EVONIK INDUSTRIES AG
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENTS
21.5 THE LUBRIZOL CORPORATION (A SUBSIDIARY OF BERKSHIRE HATHAWAY INC.)
21.5.1 COMPANY SNAPSHOT
21.5.2 REVENUE ANALYSIS
21.5.3 COMPANY SHARE ANALYSIS
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENT
21.6 BASF SE
21.6.1 COMPANY SNAPSHOT
21.6.2 REVENUE ANALYSIS
21.6.3 PRODUCT PORTFOLIO
21.6.4 RECENT DEVELOPMENTS
21.7 ASHLAND
21.7.1 COMPANY SNAPSHOT
21.7.2 REVENUE ANALYSIS
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 KERRY GROUP PLC
21.8.1 COMPANY SNAPSHOT
21.8.2 REVENUE ANALYSIS
21.8.3 PRODUCT PORTFOLIO
21.8.4 RECENT DEVELOPMENTS
21.9 SHIN-ETSU CHEMICAL CO., LTD.
21.9.1 COMPANY SNAPSHOT
21.9.2 REVENUE ANALYSIS
21.9.3 PRODUCT PORTFOLIO
21.9.4 RECENT DEVELOPMENTS
21.1 COLORCON
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENTS
21.11 ADM
21.11.1 COMPANY SNAPSHOT
21.11.2 REVENUE ANALYSIS
21.11.3 PRODUCT PORTFOLIO
21.11.4 RECENT DEVELOPMENTS
21.12 AVANTOR, INC.
21.12.1 COMPANY SNAPSHOT
21.12.2 REVENUE ANALYSIS
21.12.3 PRODUCT PORTFOLIO
21.12.4 RECENT DEVELOPMENTS
21.13 BENEO
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENTS
21.14 CHEMISCHE FABRIK BUDENHEIM
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENTS
21.15 CRODA INTERNATIONAL PLC
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENTS
21.16 DFE PHARMA
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 MEGGLE GROUP WASSERBURG
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENTS
21.18 OMYA AG
21.18.1 COMPANY SNAPSHOT
21.18.2 PRODUCT PORTFOLIO
21.18.3 RECENT DEVELOPMENTS
21.19 PETER GREVEN GMBH & CO. KG
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
21.2 PFANSTIEHL, INC.
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN, 2017-2028 (USD MILLION)
TABLE 2 NORTH AMERICA ORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 3 NORTH AMERICA INORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 4 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 5 NORTH AMERICA PRIMARY EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 6 NORTH AMERICA SECONDARY EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 7 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 8 NORTH AMERICA POLYMERS EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 9 NORTH AMERICA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 10 NORTH AMERICA SUGARS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 11 NORTH AMERICA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 12 NORTH AMERICA ALCOHOLS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 13 NORTH AMERICA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 14 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 15 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 16 NORTH AMERICA GELATIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 17 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 18 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PLANT IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ANIMALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 21 NORTH AMERICA SYNTHETIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 22 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 23 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 24 NORTH AMERICA LACTOSE MONOHYDRATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 25 NORTH AMERICA SUCRALOSE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 26 NORTH AMERICA POLYSORBATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 27 NORTH AMERICA BENZYL ALCOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 28 NORTH AMERICA CETOSTEARY ACLOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 29 NORTH AMERICA SOY LECITHIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 30 NORTH AMERICA PREGELATINIZED STARCH IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 32 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 33 NORTH AMERICA BINDERS AND ADHESIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 34 NORTH AMERICA DISINTEGRANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 35 NORTH AMERICA COATING MATERIAL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 36 NORTH AMERICA COLORING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 37 NORTH AMERICA SOLUBILIZERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 38 NORTH AMERICA FLAVORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 39 NORTH AMERICA SWEETENING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 40 NORTH AMERICA DILUENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 41 NORTH AMERICA LUBRICANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 42 NORTH AMERICA BUFFERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 43 NORTH AMERICA EMULSIFYING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PRESERVATIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 45 NORTH AMERICA ANTIOXIDANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 46 NORTH AMERICA SORBENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 47 NORTH AMERICA SOLVENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 48 NORTH AMERICA EMOLLIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 49 NORTH AMERICA GLIDIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 50 NORTH AMERICA CHELATING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 51 NORTH AMERICA ANTIFOAMING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 52 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 53 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 54 NORTH AMERICA SOLID IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 55 NORTH AMERICA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 56 NORTH AMERICA SEMI- SOLID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 57 NORTH AMERICA SEMI- SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 58 NORTH AMERICA LIQUID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 59 NORTH AMERICA LIQUID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 60 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 61 NORTH AMERICA ORAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 62 NORTH AMERICA TOPICAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 63 NORTH AMERICA PARENTERAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 64 NORTH AMERICA OTHER EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 65 NORTH AMERICA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 67 NORTH AMERICA CONTRACT FORMULATORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 68 NORTH AMERICA RESEARCH ORGANIZATION AND ACADEMICS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 69 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 70 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)
TABLE 71 NORTH AMERICA DIRECT TENDER IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 72 NORTH AMERICA RETAIL SALES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 73 NORTH AMERICA OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 74 NORTH AMERICA EXCIPIENTS MARKET, BY COUNTRY, 2017-2028 (USD MILLION)
TABLE 75 NORTH AMERICA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 76 NORTH AMERICA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 77 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 78 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 79 NORTH AMERICA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 80 NORTH AMERICA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 81 NORTH AMERICA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 82 NORTH AMERICA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 83 NORTH AMERICA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 84 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 85 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 86 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 87 NORTH AMERICA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 88 NORTH AMERICA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 89 NORTH AMERICA EXCIPIENTS MARKET, BY DOSAGE FORM, 2017-2028 (USD MILLION)
TABLE 90 NORTH AMERICA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORM, 2017-2028 (USD MILLION)
TABLE 91 NORTH AMERICA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 92 NORTH AMERICA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 93 NORTH AMERICA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 94 NORTH AMERICA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 95 NORTH AMERICA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 96 U.S. EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 97 U.S. EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 98 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 99 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 100 U.S. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 101 U.S. POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 102 U.S. SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 103 U.S. ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 104 U.S. MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 105 U.S. EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 106 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 107 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 108 U.S. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 109 U.S. EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 110 U.S. EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 111 U.S. SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 112 U.S. SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 113 U.S. LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 114 U.S. EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 115 U.S. EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 116 U.S. EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 117 CANADA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 118 CANADA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 119 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 120 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 121 CANADA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 122 CANADA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 123 CANADA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 124 CANADA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 125 CANADA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 126 CANADA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 127 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 128 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 129 CANADA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 130 CANADA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 131 CANADA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 132 CANADA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 133 CANADA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 134 CANADA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 135 CANADA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 136 CANDA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 137 CANADA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 138 MEXICO EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 139 MEXICO EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 140 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 141 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 142 MEXICO EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 143 MEXICO POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 144 MEXICO SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 145 MEXICO ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 146 MEXICO MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 147 MEXICO EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 148 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 149 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 150 MEXICO EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 151 MEXICO EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 152 MEXICO EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 153 MEXICO SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 154 MEXICO SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 155 MEXICO LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 156 MEXICO EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 157 MEXICO EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 158 MEXICO EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EXCIPIENTS MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EXCIPIENTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA EXCIPIENTS MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS AND INNOVATION IN BIOPHARMACEUTICALS IS DRIVING THE NORTH AMERICA EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 ORGANIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXCIPIENTS MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR EXCIPIENTS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA EXCIPIENTS MARKET
FIGURE 16 APPROVAL OF GENERIC MEDICINES BY USFDA
FIGURE 17 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, 2020
FIGURE 18 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, 2020-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, CAGR (2020-2028)
FIGURE 20 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN, LIFELINE CURVE
FIGURE 21 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, 2020
FIGURE 22 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, 2020-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, CAGR (2020-2028)
FIGURE 24 NORTH AMERICA EXCIPIENTS MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 25 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, 2020
FIGURE 26 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, CAGR (2020-2028)
FIGURE 28 NORTH AMERICA EXCIPIENTS MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 29 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020
FIGURE 30 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020-2028 (USD MILLION)
FIGURE 31 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, CAGR (2020-2028)
FIGURE 32 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMISTRY TYPE, LIFELINE CURVE
FIGURE 33 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020
FIGURE 34 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020-2028 (USD MILLION)
FIGURE 35 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, CAGR (2020-2028)
FIGURE 36 NORTH AMERICA EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, LIFELINE CURVE
FIGURE 37 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020
FIGURE 38 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020-2028 (USD MILLION)
FIGURE 39 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, CAGR (2020-2028)
FIGURE 40 NORTH AMERICA EXCIPIENTS MARKET: BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 41 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020
FIGURE 42 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020-2028 (USD MILLION)
FIGURE 43 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, CAGR (2020-2028)
FIGURE 44 NORTH AMERICA EXCIPIENTS MARKET: BY DOSAGE FORMS, LIFELINE CURVE
FIGURE 45 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 46 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)
FIGURE 47 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)
FIGURE 48 NORTH AMERICA EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 49 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, 2020
FIGURE 50 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 51 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, CAGR (2020-2028)
FIGURE 52 NORTH AMERICA EXCIPIENTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 54 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, 2020-2028 (USD MILLION)
FIGURE 55 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, CAGR (2020-2028)
FIGURE 56 NORTH AMERICA EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, LIFELINE CURVE
FIGURE 57 NORTH AMERICA EXCIPIENTS MARKET: SNAPSHOT (2020)
FIGURE 58 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2020)
FIGURE 59 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 60 NORTH AMERICA EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 61 NORTH AMERICA EXCIPIENTS MARKET: BY ORIGIN (2021-2028)
FIGURE 62 NORTH AMERICA EXCIPIENTS MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
